Literature DB >> 3260917

Peripheral murine CD3+, CD4-, CD8- T lymphocytes express novel T cell receptor gamma delta structures.

R Q Cron1, F Koning, W L Maloy, D Pardoll, J E Coligan, J A Bluestone.   

Abstract

A mAb directed against the CD3 molecule was used to identify a subset of CD3+, CD4-, CD8- T cells previously undefined in the peripheral lymphoid organs of the mouse. Biochemical analysis of CD3+, CD4-, CD8- splenocytes revealed that the vast majority of these cells express one of at least two distinct CD3-associated TCR gamma delta heterodimeric structures, but no detectable TCR alpha beta. One disulfide-linked heterodimer (77 kDa) is composed of two chains of 45 to 46 and 32 kDa. The latter chain was immunoprecipitated with an anti-TCR C gamma 1/C gamma 2 antiserum and was not glycosylated. An antiserum produced against a peptide corresponding to the C-terminal region of the predicted C gamma 4 gene product immunoprecipitated additional heterodimers (80 to 90 kDa). One heterodimer, composed of disulfide-linked 41- to 45-kDa protein (including a V gamma/C gamma 4 component), is expressed on a T cell hybridoma, DN-1.21, which was derived from fused splenic CD3+, CD4-, CD8- T cells. Another V gamma/C gamma 4-containing heterodimer is composed of disulfide-linked 46- to 47-kDa glycoproteins. These findings demonstrate that CD3+, CD4-, CD8- T cells present in the peripheral lymphoid organs express a variety of paired TCR gamma delta proteins. Unlike CD3+, CD4-, CD8- thymocytes, these cells express high levels of C gamma 4, but little, if any TCR alpha beta.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260917

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  The role of gamma delta T cells in the normal and disordered immune system.

Authors:  B Bröker; P M Lydyard; F Emmrich
Journal:  Klin Wochenschr       Date:  1990-05-17

2.  Phenotypic characterization of two cell populations involved in the acquisition of suppressor activity by cultured spleen cells from Mycobacterium lepraemurium-infected mice.

Authors:  D Gosselin; R Turcotte; S Lemieux
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

3.  Lymphocytes infiltrating normal human lung and lung carcinomas rarely express gamma delta T cell antigen receptors.

Authors:  I Fajac; A Tazi; A J Hance; F Bouchonnet; M Riquet; J P Battesti; P Soler
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

4.  Influence of CpG methylation and target spacing on V(D)J recombination in a transgenic substrate.

Authors:  P Engler; A Weng; U Storb
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

5.  Polymorphisms and diversity of T-cell receptor-gamma proteins expressed in mouse spleen.

Authors:  R Q Cron; J E Coligan; J A Bluestone
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

6.  The gamma chain of the high-affinity receptor for IgE is a major functional subunit of the T-cell antigen receptor complex in gamma delta T lymphocytes.

Authors:  D Qian; A I Sperling; D W Lancki; Y Tatsumi; T A Barrett; J A Bluestone; F W Fitch
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

7.  TCR3: a third T-cell receptor in the chicken.

Authors:  C H Chen; J T Sowder; J M Lahti; J Cihak; U Lösch; M D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Excision products of the T cell receptor gene support a progressive rearrangement model of the alpha/delta locus.

Authors:  S Takeshita; M Toda; H Yamagishi
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

9.  Highly restricted expression of the thymus leukemia antigens on intestinal epithelial cells.

Authors:  M Wu; L van Kaer; S Itohara; S Tonegawa
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

10.  Blockade of transgenic gamma delta T cell development in beta 2-microglobulin deficient mice.

Authors:  P Pereira; M Zijlstra; J McMaster; J M Loring; R Jaenisch; S Tonegawa
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.